Repetitive use of levosimendan for treatment of chronic advanced heart failure: Clinical evidence, practical considerations, and perspectives: An expert panel consensus
Why the study?
Does intermittent/repetitive levosimendan maintain patient stability in advanced chronic heart failure?
Population
Patients with advanced chronic, but not necessarily acutely decompensated, heart failure
Design
Guideline
Authors
Discussion
Loading...
Member takes
Implication
May support intermittent levosimendan for stability in selected advanced HF outpatients; extends consensus while underscoring need for definitive RCTs.
Structured PICO
Does intermittent/repetitive levosimendan maintain patient stability in advanced chronic heart failure?
P
Population
Patients with advanced chronic, but not necessarily acutely decompensated, heart failure
I
Intervention
Intermittent/repetitive intravenous levosimendan
Expert consensus suggests intermittent levosimendan may be considered in selected patients with advanced chronic heart failure to maintain stability, though further definitive trials are needed.
Limitations
- Existing data requires further exploration to allow for definitive conclusions on safety and clinical efficacy
- Further studies needed focusing on morbidity and mortality outcomes, dosing intervals, and patient monitoring
Cite This Study
Nieminen et al. (2014) studied this question.